Tovorafenib Impurity 24 | CAS 914916-96-4 - Request Quote
Tovorafenib Impurity 24
| SZ CAT No: | SZ-T202032 |
| CAS No | 914916-96-4 |
| Mol.F. | C5H3ClN2O3 |
| Mol.Wt. | 174.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tovorafenib Impurity 24 is chemically 5-Chloro-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid. Tovorafenib Impurity 24 is supplied with detailed characterization data compliant with regulatory guideline. Tovorafenib Impurity 24 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tovorafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 914916-96-4
Purchase 914916-96-4
Order 914916-96-4
Enquire 914916-96-4
price of 914916-96-4
914916-96-4 Supplier
914916-96-4 Manufacturer
914916-96-4 Exporter
buy high quality Tovorafenib Impurity 24
Purchase Tovorafenib Impurity 24
Tovorafenib Impurity 24 suppliers
Tovorafenib Impurity 24 manufacturers
Tovorafenib Impurity 24 price
Order Tovorafenib Impurity 24
Enquire Tovorafenib Impurity 24
Tovorafenib Impurity 24 cost
Tovorafenib Impurity 24 Supplier
Tovorafenib Impurity 24 Distributor
Tovorafenib Impurity 24 for Method Validation
Tovorafenib Reference Standard
Tovorafenib Impurity 24 for ANDA Filing
Tovorafenib Impurity 24 for Forced Degradation Studies
Tovorafenib Impurity 24 Identification Standards
Tovorafenib Impurity 24 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


